Shareholding for the Period Ended December 31, 2017
HealthCare Global Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here19-01-2018
19-01-2018
Statement Of Investor Complaints For The Quarter Ended December, 2017.
Statement of Investor Complaints for the Quarter ended December, 2017.18-01-2018
HCG's Triesta unit inks agreement with Strand Life Sciences to combine businesses
Healthcare Global Enterprises (HCG) has announced execution of definitive agreements for the business combination of its Triesta Sciences business unit with Strand Life Sciences.05-01-2018
Memorandum of Understanding /Agreements
This is to inform you that, the Company has entered into definitive agreements providing for a business combination (hereinafter referred to as the 'Business Combination') of its Triesta Sciences business unit ('Triesta Sciences'), with Strand Life Sciences Private Limited, a company incorporated under the Companies Act, 1956. The Company has entered into a Business Transfer Agreement ('BTA'), a Share Subscription Agreement ('SSA') and a...03-01-2018
Allotment
Pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, vide resolution passed by Circulation today i.e., December 28, 2017, has approved the allotment of 11,66,667 (Eleven Lakh Sixty Six Thousand Six Hundred Sixty Seven) equity shares of Rs. 10 each of the Company, at a price of Rs. 300 per share (including share premium of Rs. 290 per share), on Preferential...28-12-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for First State Investment Management (UK) Ltd27-12-2017
HCG JV with Cvergenx to develop genomic radiation therapy
HCG has entered into a joint venture with Cvergenx to develop, validate and launch precision genomic radiation therapy (pGRTTM) technology in India and Africa. This joint venture will be an exclusive...25-12-2017